Kymera Therapeutics

Kymera Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

WATERTOWN, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company will participate in a virtual